Wiley Corporate Logo

Top Navigation

Virtual Issue: Cancer Proteomics

The drive for ‘individualized’ medicine recognizes the need to treat each patient on an individual basis rather than just on a generic disease basis and highlights the real need for more biomarkers. Clinical proteomics has the potential to really contribute to the biomarker discovery process, and also in defining or streamlining new therapeutic targets from identifying key factors implicated mechanistically in the underlying disease process.

The following virtual issues bring together collections of recently published articles from Proteomics Clinical Applications which illustrate the diverse proteomic approaches being taken across many cancer types, focusing on analysis of body fluids as well as analysis of cells and tissues, in the drive to deliver findings which may ultimately translate to the clinic.

The Virtual Issues on Cancer Proteomics – Body Fluids and Cancer Proteomics – Cells and Tissues are now available and free to access until the end of May 2012.

Browse the articles in these exciting collections now.

Also of interest:

Proteomics E-Newsletter

Publish your next paper in Proteomics Clinical Application

Asia Oceania Human Proteome Organization 6th Congress, Beijing, China

, , , , , ,